Kevin A. Hommel, PhD

Pediatric Psychologist, Research, Behavioral Medicine & Clinical Psychology

Director, Divisional Data Core

Center for Adherence and Self-Management

Associate Professor, UC Department of Pediatrics

Phone 513-636-4336

Fax 513-803-0415



Promotion of treatment adherence; self-management in pediatric chronic conditions


Adherence and self-management assessment methodology; behavioral treatment of nonadherence; promotion of self-management behavior; impact of adherence and self-management on health outcomes; quality of life in pediatric chronic conditions

Visit the Hommel Lab.

Dr. Hommel's research is currently funded by the National Institutes of Health: National Institute of Child Health and Human Development and National Institute of Diabetes and Digestive and Kidney Diseases. Many of his studies are focused on developing, testing (via randomized controlled trial), and optimizing behavioral treatments for nonadherence in inflammatory bowel disease (IBD), as well as examining the effects of nonadherence on disease outcomes and health-related quality of life (HRQoL). Dr. Hommel is also involved in studies that are aimed at developing HRQoL measures in functional gastrointestinal disorders (FGID) and eosinophilic esophagitis. He is a co-investigator on the PROTECT study, which is a multisite U01 study aimed at defining the rate of corticosteroid-free remission in pediatric patients with ulcerative colitis receiving standardized medical therapy. Additionally, Dr. Hommel is a co-investigator on a multisite R01 study aimed at developing and testing a collaborative chronic care network (C3N) to improve treatment outcomes in children with IBD.

Dr. Hommel came to Cincinnati Children's Hospital Medical Center in 2008 from the Children's Hospital of Philadelphia and the University of Pennsylvania School of Medicine. He continues to collaborate with investigators at the Children's Hospital of Philadelphia as a site principal investigator on two studies funded by the NIDDK. The first is evaluating the efficacy of a low magnitude mechanical stimulus intervention to improve bone mineral density in children with Crohn's disease and the second is examining the effects of a novel lipid matrix supplement on choline status in children with cystic fibrosis.

BA: University of Central Oklahoma, 1996.

MS: Oklahoma State University,1999.

PhD: Oklahoma State University, 2002.

Residency: Cincinnati Children's Hospital Medical Center, 2002.

Fellowship: Cincinnati Children's Hospital Medical Center, 2004.

View PubMed Publications

Hommel KA, Franciosi JP, Gray WN, Hente EA, Ahrens A, Rothenberg ME. Behavioral functioning and treatment adherence in pediatric eosinophilic gastrointestinal disorders. Pediatr Allergy Immunol. 2012 Aug:23(5):494-9.

Franciosi JP, Hommel KA, DeBrosse CW, Greenler AJ, Greenberg AB, Abonia JP, Rothenberg ME, Varni JW. Quality of Life in Paediatric Eosinophilic Oesophagitis: What is Important to Patients? Child: Care, Health, and Development. 38(4): 477-483. 2012.

Hommel KA, Hente EA, Odell S, Herzer M, Ingerski LM, Guilfoyle SM, Denson LA. Evaluation of a Group-Based Behavioral Intervention to Promote Adherence in Adolescents with Inflammatory Bowel Disease. European Journal of Gastroenterology and Hepatology. 24(1): 64-69. 2012.

Gray WN, Denson LA, Baldassano RN, Hommel KA. Treatment Adherence in Adolescents with Inflammatory Bowel Disease: The Collective Impact of Barriers to Adherence and Anxiety/Depressive Symptoms. Journal of Pediatric Psychology. 37(3): 282-291. 2012.

Hommel KA, Franciosi JP, Hente EA, Ahrens A, Rothenberg ME. Treatment Adherence in Pediatric Eosinophilic Gastrointestinal Disorders. Journal of Pediatric Psychology. 37(5): 533-542. 2012.

Modi AC, Pai AL, Hommel KA, Hood KK, Cortina S, Hilliard ME, Guilfoyle SM, Gray WN, Drotar D. Pediatric self-management: A framework for research, practice, and policy. Pediatrics. 129(2): E473-485. 2012.

Guilfoyle SM, Denson LA, Baldassano RN, Hommel KA. Paediatric parenting stress in inflammatory bowel disease: Application of the Pediatric Inventory for Parents. Child: Care, Health and Development. 38(2): 273-279. 2012.

Hommel KA, Herzer M, Ingerski LM, Hente EA, Denson LA. Individually-tailored treatment of medication nonadherence: A pilot study. Journal of Pediatric Gastroenterology and Nutrition. 2011.

Herzer M, Denson LA, Baldassano RN, Hommel KA. Family functioning and health-related quality of life in adolescents with pediatric inflammatory bowel disease. Eur J Gastroenterol Hepatol. Jan;23(1):95-100. 2011.

Hommel KA, Odell S, Sander E, Baldassano RN, Barg FK. Treatment adherence in paediatric inflammatory bowel disease: perceptions from adolescent patients and their families. Health Soc Care Community. Jan;19(1):80-8. 2011.

Telehealth Enhancement of Adherence to Medication in Pediatric IBD (TEAM Study). Principal Investigator. National Institutes of Health / National Institute of Child Health and Human Development. 2011-2016.

Predicting Response to Standard Pediatric Colitis Therapy: The PROTECT study. Co-Investigator. National Institute of Diabetes and Digestive and Kidney Diseases. 2012-2017.